A trail of complaints at pharmacy linked to meningitis deaths
Records show that inspectors knew about problems with an injectable steroid produced at the New England Compounding Center going back to 2002. The same tainted drug allegedly to blame for 23 meningitis deaths. Both documents, as well as testimony before a congressional committee, suggest a pattern of violations and modest penalties for the Framingham specialty pharmacy.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Hospitals Likely to Outsource ICD-10 at Launch
- Anatomy of 3 Health System Rebranding Efforts